The lncRNA ANRIL was first reported to contribute to the pathogenesis of diabetic kidney disease via regulation of the cyclin-dependent kinase inhibitor (CKDN) pathway [17]. This evidence concerns the gene CDKN2B-AS1 and diabetic kidney disease.